Cardiac Involvement in Scleroderma

Handbook of Systemic Autoimmune Diseases

Volumn 1, Issue , 2003, Pages 189-195

  Gerry Coghlan, J ^a   Denton, Christopher P ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649659707     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(03)01012-2     Document Type: Review

References (43)

1. Abbott K.C., Trespalacios F.C., Welch P.G., and Agodoa L.Y. Scleroderma at end stage renal disease in the United States: patient characteristics and survival. J. Nephrol. 15 (2002) 236
2. Alexander E.L., Firestein G.S., Weiss J.L., Heuser R.R., Leitl G., Wagner Jr. H.N., Brinker J.A., Ciuffo A.A., and Becker L.C. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann. Intern. Med. 105 (1986) 661
3. Armstrong G.P., Whalley G.A., Doughty R.N., Gamble G.D., Flett S.M., Tan P.L., and Sharpe D.N. Left ventricular function in scleroderma. Br. J. Rheumatol. 35 (1996) 983
4. Bulkley B.H., Ridolfi R.L., Salyer W.R., and Hutchins G.M. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 53 (1976) 483
5. Bulkley B.H., Klacsmann P.G., and Hutchins G.M. Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis. Am. Heart J. 95 (1978) 563 An early series recognizing that cardiac involvement was an important cause of death in systemic sclerosis but was not always associated with structural pathology
6. Bulpitt K.J., Clements P.J., Lachenbruch P.A., Paulus H.E., Peter J.B., Agopian M.S., Singer J.Z., Steen V.D., Clegg D.O., and Ziminski C.M. Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann. Intern. Med. 118 (1993) 602
7. Candell-Riera J., Armadans-Gil L., Simeon C.P., Castell-Conesa J., Fonollosa-Pla V., Garcia-del-Castillo H., Vaque-Rafart J., Vilardell M., and Soler-Soler J. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum. 39 (1996) 1138
8. Cheng K.S., Tiwari A., Boutin A., Denton C.P., Black C.M., Morris R., Seifalian A.M., and Hamilton G. Differentiation of primary and secondary Raynaud's disease by carotid arterial stiffness. Eur. J. Vasc. Endovasc. Surg. 25 (2003) 336
9. Cheng K.S., Tiwari A., Boutin A., Denton C.P., Black C.M., Morris R., Hamilton G., and Seifalian A.M. Carotid and femoral arterial wall mechanics in scleroderma. Rheumatology 42 (2003) 1299
10. Chung G., and Lahiri A. Myocardial perfusion imaging in modern cardiology. Br. J. Cardiol. 7 (2000) 619
11. Colfer H.T., Das S.K., Dabich L., Randall O.S., and Pitt B. Effect of cold stress on coronary sinus blood flow in patients with scleroderma. J. Assoc. Acad. Minor. Phys. 4 (1993) 62
12. Di Bello V., Ferri C., Giorgi D., Bianchi M., Bertini A., Martini A., Storino F.A., Paterni M., Pasero G., and Giusti C. Ultrasonic videodensitometric analysis in scleroderma heart disease. Coron. Artery Dis. 10 (1999) 103
13. Follansbee W.P., Curtiss E.I., Rahko P.S., Medsger Jr. T.A., Lavine S.J., Owens G.R., and Steen V.D. The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature. Am. J. Med. 79 (1985) 183
14. Follansbee W.P., Miller T.R., Curtiss E.I., Orie J.E., Bernstein R.L., Kiernan J.M., and Medsger Jr. T.A. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J. Rheumatol. 17 (1990) 656 Seminal paper describing cardiac involvement with fibrosis in systemic sclerosis that establishes a substantial prevalence of subclinical disease
15. Follansbee W., Zerbe T., and Medsger T. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am. Heart J. 125 (1993) 194
16. Geirsson A., Danielsen R., and Petursson E. Left ventricular myocardial perfusion and function in systemic sclerosis before and after diltiazem treatment. Scand. J. Rheumatol. 25 (1996) 317
17. Gupta M.P., Zoneraich S., Zeitlin W., Zoneraich O., and D'Angelo W. Scleroderma heart disease with slow flow velocity in coronary arteries. Chest 67 (1975) 116
18. Ho M., Veale D., Eastmond C., Eastmond C., Nuki G., and Belch J. Macrovascular disease and systemic sclerosis. Ann. Rheum. Dis. 59 (2000) 39
19. Ishida R., Murata Y., Sawada Y., Nishioka K., and Shibuya H. Thallium-201 myocardial SPECT in patients with collagen disease. Nucl. Med. Commun. 21 (2000) 729
20. Josephson M. Intraventricular Conduction Disturbances. Clinical Cardiac Electrophysiology. 2nd ed. (1993), Lea and Febiger, Philadelphia, PA p. 117
21. Kannel W.B., and Castelli W.P. The Framingham study of coronary disease in women. Med. Times 100 (1972) 173
22. Kissin E., and Korn J.H. Poptosis and myofibroblasts in the pathogenesis of systemic sclerosis. Curr. Rheumatol. Rep. 4 (2002) 129
23. Lee P., Langevitz P., Alderdice C.A., Aubrey M., Baer P.A., Baron M., Buskila D., Dutz J.P., Khostanteen I., and Piper S. Mortality in systemic sclerosis (scleroderma). Q. J. Med. 82 (1992) 139
24. Lekakis J., Mavrikakis M., Emmanuel M., Prassopoulos V., Papazoglou S., Papamichael C., Moulopoulou D., Kostamis P., Stamatelopoulos S., and Moulopoulos S. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis. Clin. Exp. Rheumatol. 16 (1998) 135
25. Liangos O., Neure L., Kuhl U., Pauschinger M., Sieper J., Distler A., Schwimmbeck P.L., and Braun J. The possible role of myocardial biopsy in systemic sclerosis. Rheumatology (Oxford) 39 (2000) 674
26. Morelli S., Piccirillo G., Fimognari F., Sgreccia A., Ferrante L., Morabito G., DeMarzio P., Valesini G., and Marigliano V. Twenty-four hour heart period variability in systemic sclerosis. J. Rheumatol. 23 (1996) 643 This paper confirms that there is likely to be altered cardiac electrophysiology in many patients with systemic sclerosis although the clinical and therapeutic implications remain uncertain
27. Morelli S., Sgreccia A., De Marzio P., Perrone C., Ferrante L., Gurgo A.M., Gurgo diCastelmenardo A.M., Aguglia G., De Vincentiis G., Scopinaro F., and Calvieri S. Noninvasive assessment of myocardial involvement in patients with systemic sclerosis: role of signal averaged electrocardiography. J. Rheumatol. 24 (1997) 2358
28. Morton V., and Torgerson D. Effect of regression to the mean on decision making in health care. Br. Med. J. 326 (2003) 1083
29. Mukerjee D., St. George D., Coleiro B., Denton C.P., Devar J., Black C.M., and Coghlan J.G. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension (SScPAH): application of a registry approach. Annals Rheum Disease. (2003) Ann Rheum Dis. 62: 1088-93
30. Nakajima K., Taki J., Kawano M., Higuchi T., Sato S., Nishijima C., Takehara K., and Tonami N. Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement. J. Nucl. Med. 42 (2001) 183
31. Nishioka K., Katayama I., Kondo H., Shinkai H., Ueki H., Tamaki K., Takehara K., Tajima S., Maeda M., Hayashi S., Kodama H., Miyachi Y., Mizutani H., Fujisaku A., Sasaki T., Shimizu M., and Kaburagi J. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan. J. Dermatol. 23 (1996) 677
32. Nitenberg A., Foult J.M., Kahan A., Perennec J., Devaux J.Y., Menkes C.J., and Amor B. Reduced coronary flow and resistance reserve in primary scleroderma myocardial disease. Am. Heart J. 112 (1986) 309
33. Plazak W., Zabinska-Plazak E., Wojas-Pelc A., Podolec P., Olszowska M., Tracz W., and Bogdaszewska-Czabanowska J. Heart structure and function in systemic sclerosis. Eur. J. Dermatol. 12 (2002) 257
34. Ruangjutipopan S., Kasitanon N., Louthrenoo W., Sukitawut W., and Wichainun R. Causes of death and poor survival prognostic factors in Thai patients with systemic sclerosis. J. Med. Assoc. Thai. 85 (2002) 1204
35. Schachna L., and Wigley F.M. Targeting mediators of vascular injury in scleroderma. Curr. Opin. Rheumatol. 14 (2002) 686
36. Steen V.D., and Medsger Jr. T.A. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 43 (2000) 2437
37. Steen V.D., Follansbee W.P., Conte C.G., and Medsger Jr. T.A. Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum. 39 (1996) 677
38. Task Force of the ESC. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 24 (2003) 28
39. Taylor M.H., McFadden J.A., Bolster M.B., and Silver R.M. Ulnar artery involvement in systemic sclerosis (scleroderma). J. Rheumatol. 29 (2002) 102
40. Veale D.J., Collidge T.A., and Belch J.J. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann. Rheum. Dis. 54 (1995) 853
41. Vlachoyiannopoulos P.G., Dafni U.G., Pakas I., Spyropoulou-Vlachou M., Stavropoulos-Giokas C., and Moutsopoulos H.M. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele. Ann. Rheum. Dis. 59 (2000) 359
42. Wranicz J.K., Strzonda M., Zieliska M., Cygankiewicz I., Ruta J., Dziankowska-Bartkowiak B., and Sysa-Jedrzejowska A. Evaluation of early cardiovascular involvement in patients with systemic sclerosis. Przegl. Lek. 57 (2000) 389
43. Youssef P., Englert H., and Bertouch J. Large vessel occlusive disease associated with CREST syndrome and scleroderma. Ann. Rheum. Dis. 52 (1993) 464 The first report of increased macrovascular disease in systemic sclerosis. Occult left ventricular cardiac involvement may first present at times of cardiovascular stress related to the disease (e.g. hypertensive renal crisis) or related to high volume fluid loads associated therapy or as a result of cardiotoxic drugs